Poly Medicure
Ticker > Company >

Poly Medicure share price

Poly Medicure Ltd.

NSE: POLYMED BSE: 531768 SECTOR: Medical Equipment/Supplies/Accessories  117k   559   80

2,514.80
-12.00 (-0.47%)
NSE: Today, 10:34 AM

Price Summary

Today's High

₹ 2,582.80

Today's Low

₹ 2,485

52 Week High

₹ 3,357.80

52 Week Low

₹ 1,584.80

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 25,481.39 Cr.

Enterprise Value

₹ 25,505.02 Cr.

No. of Shares

10.13 Cr.

P/E

76.91

P/B

9.29

Face Value

₹ 5

Div. Yield

0.14 %

Book Value (TTM)

₹  270.83

CASH

₹ 136.95 Cr.

DEBT

₹ 160.58 Cr.

Promoter Holding

62.44 %

EPS (TTM)

₹  32.70

Sales Growth

22.40%

ROE

18.74 %

ROCE

23.28%

Profit Growth

40.59 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Search for a Ratio
Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 22 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.4%
3 Year20.49%
5 Year17.38%

Profit Growth

1 Year40.59%
3 Year24.8%
5 Year30.59%

ROE%

1 Year18.74%
3 Year16.22%
5 Year18.05%

ROCE %

1 Year23.28%
3 Year20.1%
5 Year21.31%

Debt/Equity

0.11

Price to Cash Flow

99.50

Interest Cover Ratio

27.06

CFO/PAT (5 Yr. Avg.)

1.03

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 62.44 0.00
Dec 2024 62.44 0.00
Sep 2024 62.56 0.00
Jun 2024 66.03 0.00
Mar 2024 53.15 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 24.80% for the Past 3 years.
  • The company has shown a good revenue growth of 20.49% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 20.10% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 27.06.
  • The Company has been maintaining an effective average operating margins of 25.76% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 35.16 days.
  • Company has a healthy liquidity position with current ratio of 2.16.
  • The company has a good cash flow management; CFO/PAT stands at 1.03.
  • The company has a high promoter holding of 62.44%.

 Limitations

  • The company is trading at a high PE of 76.91.
  • The company is trading at a high EV/EBITDA of 48.01.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 360.93 367.43 402.47 410.94 420.97
Total Expenditure 263.64 266.23 289.54 295.34 304.93
Operating Profit 97.28 101.20 112.93 115.60 116.04
Other Income 15.66 16.83 27.24 21.75 23.95
Interest 2.93 2.98 3.13 3.13 2.17
Depreciation 16.04 18.98 20.11 20.83 21.33
Exceptional Items 0 0 0 0 0
Profit Before Tax 93.97 96.07 116.93 113.39 116.50
Tax 23.44 23.77 29.71 28.24 29.84
Profit After Tax 70.53 72.30 87.22 85.15 86.66
Adjusted EPS (Rs) 7.35 7.53 8.61 8.40 8.55

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 646.16 747.38 879.36 1,068.05 1,307.25
Total Expenditure 483.92 537.03 665.47 801.67 955.63
Operating Profit 162.24 210.36 213.89 266.37 351.62
Other Income 18.58 19.29 38.73 36.29 58.18
Interest 19.76 9.95 5.36 10.19 12.85
Depreciation 39.28 46.31 52.54 55.64 62.05
Exceptional Items 0 0 0 0 0
Profit Before Tax 121.78 173.38 194.72 236.83 334.89
Tax 29.40 43.87 48.70 57.78 83.17
Net Profit 92.38 129.51 146.02 179.04 251.72
Adjusted EPS (Rs.) 10.47 13.51 15.23 18.66 26.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 44.12 47.94 47.95 47.97 47.99
Total Reserves 385.16 906.07 1,029.02 1,186.15 1,410.26
Borrowings 110.57 59.74 30.56 11.56 1.09
Other N/C liabilities 23.92 21.67 23.15 23.13 34.48
Current liabilities 208.27 195.54 203.27 326.81 400.35
Total Liabilities 772.05 1,230.96 1,333.96 1,595.63 1,894.16
Assets
Net Block 324.16 384.97 447.46 597.43 830.82
Capital WIP 16.70 14.74 37.11 72.53 66.67
Intangible WIP 7.88 6.43 5.86 5.21 4.04
Investments 42.03 39.80 46.94 56.96 81.07
Loans & Advances 19.54 12.73 31.85 41.89 38.63
Other N/C Assets 36.33 55.06 23.75 8.49 8.33
Current Assets 325.40 717.23 740.99 813.13 864.59
Total Assets 772.05 1,230.96 1,333.96 1,595.63 1,894.16
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 121.78 173.38 194.72 236.83 334.89
Adjustment 50.36 44.94 38.60 60.17 35.82
Changes in Assets & Liabilities -9.66 -57.79 -60.19 -42.33 -40.87
Tax Paid -35.58 -44.14 -46.86 -57.84 -73.74
Operating Cash Flow 126.91 116.40 126.26 196.83 256.10
Investing Cash Flow -105.67 -434.41 -88.71 -189.18 -237.02
Financing Cash Flow -22.25 318.92 -39.71 -7.89 -17.32
Net Cash Flow -1.02 0.90 -2.16 -0.25 1.76

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 53.15 66.03 62.56 62.44 62.44
aaryaman baid 0.29 0.29 0.28 0.28 0.28
arham baid 0.29 0.29 0.28 0.28 0.28
dhruv baid 0.38 0.38 0.36 0.36 0.36
ezekiel global business s... - 12.88 12.20 12.20 12.20
himanshu baid 8.24 8.24 7.81 7.80 7.80
himanshu baid (huf) 4.00 - 3.79 3.79 3.79
jai polypan pvt. ltd. 3.49 - 3.31 3.26 3.26
jugal kishore baid 2.38 2.38 2.25 2.25 2.25
madhu kothari 0.16 0.16 0.15 0.15 0.15
neha baid - - - - 1.01
polycure martech limited 0.01 0.01 0.01 0.01 0.01
rishi baid 10.18 10.18 9.64 9.59 9.59
rishi baid (huf) 2.90 - 2.74 2.74 2.74
shaily baid 1.24 1.24 1.17 1.17 1.17
shireen baid - - - - 1.11
smt. mukulika baid - - 3.02 3.02 3.02
vcb trading llp 3.69 3.69 3.50 3.49 3.49
vinay kothari 0.06 0.06 0.06 0.06 0.06
vishal baid 1.75 1.75 1.66 1.66 1.66
zetta matrix consulting l... 8.67 8.67 8.22 8.21 8.21
neha baid 1.07 1.07 1.01 1.01 -
shireen baid 1.17 1.17 1.11 1.11 -
himanshu baid (huf) - 4.00 - - -
jai polypan pvt. ltd - 3.49 - - -
rishi baid(huf) - 2.90 - - -
smt.mukulika baid 3.19 3.19 - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 46.85 33.97 37.44 37.56 37.56
axis max life insurance l... - - - - 1.94
lighthouse india fund iv ... - - 1.16 1.37 1.37
nirmala vinodkumar daga 2.18 2.12 1.84 1.80 1.80
quant mutual fund - quant... - - - - 3.35
shreans daga 1.53 1.53 1.45 1.43 1.43
smallcap world fund, inc 2.26 2.26 1.79 1.66 1.66
uti nifty midsmallcap 400... - - - - 1.62
varun daga 1.62 1.62 1.54 1.54 1.54
max life insurance co ltd... - - - 1.67 -
quant mutual fund - quant... - - 3.51 3.51 -
uti - healthcare fund 2.25 2.02 1.78 1.66 -
max life insurance compan... - - 1.71 - -
max life insurance compan... - 1.54 - - -
quant mutual fund - quant... - 3.43 - - -
ezekiel global business s... 12.88 - - - -
lighthouse india iii equi... 2.94 - - - -
max life insurance co. lt... 1.12 - - - -
quant mutual fund - quant... 2.12 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Poly Medicure reports 34% jump in Q4 consolidated net profit 7 May, 3:22 PM Poly Medicure informs about press release 7 May, 12:15 PM Poly Medicure - Quaterly Results 6 May, 10:28 PM Poly Medicure - Quaterly Results 6 May, 10:28 PM Poly Medicure receives MDR certification for 54 products 11 Mar, 4:41 PM Poly Medicure incorporates wholly owned Step-down subsidiary 6 Feb, 9:14 AM Poly Medicure informs about unaudited financial results 3 Feb, 4:51 PM Poly Medicure - Quaterly Results 3 Feb, 2:30 PM Poly Medicure - Quaterly Results 3 Feb, 2:30 PM Poly Medicure - Quaterly Results 3 Feb, 2:30 PM Poly Medicure enters into JV agreement with AMPIN C&I Power 10 Jan, 6:42 PM Poly Medicure - Quaterly Results 28 Oct, 2:17 PM Poly Medicure - Quaterly Results 28 Oct, 2:17 PM Poly Medicure - Quaterly Results 28 Oct, 2:17 PM Poly Medicure informs about investor presentation 24 Jul, 4:41 PM Poly Medicure - Quaterly Results 22 Jul, 1:19 PM Poly Medicure - Quaterly Results 22 Jul, 1:19 PM Poly Medicure - Quaterly Results 22 Jul, 1:19 PM Poly Medicure - Quaterly Results 17 May, 2:08 PM Poly Medicure - Quaterly Results 17 May, 2:08 PM Poly Medicure - Quaterly Results 17 May, 2:08 PM Poly Medicure - Quaterly Results 31 Jan, 11:59 AM Poly Medicure - Quaterly Results 31 Jan, 11:59 AM Poly Medicure - Quaterly Results 31 Jan, 11:59 AM Poly Medicure - Quaterly Results 4 Nov, 1:47 PM Poly Medicure - Quaterly Results 4 Nov, 1:47 PM Poly Medicure - Quaterly Results 4 Nov, 1:47 PM Poly Medicure - Quaterly Results 7 Aug, 12:10 PM Poly Medicure - Quaterly Results 7 Aug, 12:10 PM Poly Medicure - Quaterly Results 7 Aug, 12:10 PM Poly Medicure - Quaterly Results 9 May, 12:57 PM Poly Medicure - Quaterly Results 9 May, 12:57 PM Poly Medicure - Quaterly Results 9 May, 12:57 PM Poly Medicure - Quaterly Results 28 Jan, 12:39 PM Poly Medicure - Quaterly Results 28 Jan, 12:39 PM Poly Medicure - Quaterly Results 28 Jan, 12:39 PM Poly Medicure informs about board meeting 17 Jan, 12:33 PM Poly Medicure - Quaterly Results 4 Nov, 12:38 PM Poly Medicure - Quaterly Results 4 Nov, 12:38 PM Poly Medicure - Quaterly Results 4 Nov, 12:38 PM Poly Medicure - Quaterly Results 4 Aug, 12:21 PM Poly Medicure - Quaterly Results 4 Aug, 12:21 PM Poly Medicure - Quaterly Results 4 Aug, 12:21 PM Poly Medicure - Quaterly Results 24 May, 12:00 PM Poly Medicure - Quaterly Results 24 May, 12:00 PM Poly Medicure informs about disclosure 30 Apr, 10:02 AM Poly Medicure informs about analyst meet 11 Feb, 4:21 PM Poly Medicure - Quaterly Results 31 Jan, 12:31 PM Poly Medicure - Quaterly Results 31 Jan, 12:31 PM Poly Medicure - Quaterly Results 1 Nov, 12:53 PM

Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Poly Medicure stock price today is Rs 2,533.10. So, let’s look into Poly Medicure and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 256.10 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Poly Medicure has a Debt to Equity ratio of 0.11 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Poly Medicure , the EPS growth was 40.55 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Poly Medicure has OPM of 26.90 % which is a good sign for profitability.
     
  • ROE: Poly Medicure have a average ROE of 18.74 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Poly Medicure is Rs 2,533.10. One can use valuation calculators of ticker to know if Poly Medicure share price is undervalued or overvalued.
Last Updated on:
Brief about Poly Medicure

Poly Medicure Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

Poly Medicure Ltd. is a leading medical device company in India. In this article, we will provide a comprehensive analysis of the company's stock, including its share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall transcripts, investor presentations, promoters, and shareholders. Our website provides pre-built screening tools and premium features such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. Additionally, we provide downloadable annual reports and quarterly results for investors to analyze.

Poly Medicure Ltd. Share Price

The share price of Poly Medicure Ltd. is an important factor to consider before investing. It reflects the market's perception of the company's performance. A stock's share price is determined by a range of factors, such as market sentiment, financial performance, and general economic conditions. Our pre-built screening tools can help investors analyze the stock price and its trend. Investors should analyze the trend of the share price over a period of time to make informed decisions.

Poly Medicure Ltd. Balance Sheet

The balance sheet of Poly Medicure Ltd. provides information on the company's assets, liabilities, and equity. It is important to analyze the balance sheet to understand the financial position of the company. Our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, can help investors calculate the fair value of the company.

Poly Medicure Ltd. Annual Report

The annual report of Poly Medicure Ltd. provides a comprehensive overview of the company's performance over the year. It includes information on the company's financial statements, management discussion and analysis, and corporate governance. Investors can download the annual report from our website and analyze it to understand the company's performance.

Poly Medicure Ltd. Dividend

Poly Medicure Ltd. has a history of consistently paying dividends to its shareholders. Investors can analyze the company's dividend history to understand its dividend policy. It is important to analyze the dividend payout ratio to understand how much of the company's earnings are being distributed as dividends.

Poly Medicure Ltd. Quarterly Result

The quarterly results of Poly Medicure Ltd. provide information on the company's performance over the quarter. It includes information on the company's revenue, net profit, and earnings per share. Investors can download the quarterly results from our website and analyze them to understand the company's performance.

Poly Medicure Ltd. Stock Price

The stock price of Poly Medicure Ltd. is influenced by various factors such as market conditions, company performance, and news. Investors can analyze the stock price to understand the market's perception of the company's performance. Our pre-built screening tools can help investors analyze the stock price and its trend.

Poly Medicure Ltd. Price Chart

The price chart of Poly Medicure Ltd. provides a visual representation of the stock price trend over a period of time. Investors can analyze the price chart to understand the trend of the stock price. Our pre-built screening tools can help investors analyze the price chart and its trend.

Poly Medicure Ltd. News

News plays an important role in influencing the stock price of Poly Medicure Ltd. Investors can analyze the news related to the company to understand its impact on the stock price. Our pre-built screening tools can help investors analyze the news related to the company.

Poly Medicure Ltd. Concall Transcripts

The concall transcripts of Poly Medicure Ltd. provide information on the company's performance and management's outlook for the future. Investors can download the concall transcripts from our website and analyze them to understand the company's performance.

Poly Medicure Ltd. Investor Presentations

The investor presentations of Poly Medicure Ltd. provide information on the company's strategy, performance, and outlook for the future. Investors can download the investor presentations from our website and analyze them to understand the company's performance.

Poly Medicure Ltd. Promoters

The promoters of Poly Medicure Ltd. are the individuals or entities that hold a significant stake in the company. It is important to analyze the promoters to understand their track record and their influence on the company's performance.

Poly Medicure Ltd. Shareholders

The shareholders of Poly Medicure Ltd. are the individuals or entities that own a stake in the company. It is important to analyze the shareholders to understand their influence on the company's performance.

Poly Medicure Ltd. ROCE

Return on Capital Employed (ROCE) serves as a crucial metric for assessing Poly Medicure Ltd.'s profitability and capital utilization. Investors can find the ROCE data for Poly Medicure Ltd. in the financials table or ratio section above, enabling them to gauge how effectively the company is generating returns from capital investments and utilizing its resources to create value for shareholders.

Poly Medicure Ltd. EBITDA

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) acts as a key indicator of Poly Medicure Ltd.'s operational performance and cash flow generation. By eliminating interest, taxes, and non-cash expenses such as depreciation and amortization, EBITDA reveals Poly Medicure Ltd.'s core profitability. Investors can access the EBITDA data for Poly Medicure Ltd. in the financials table or ratio section above to gain insights into the company's financial health.

Poly Medicure Ltd. DPS

Dividends Per Share (DPS) serves as a significant metric for income-seeking investors, representing Poly Medicure Ltd.'s dividend distribution relative to its share count. By reviewing the DPS data available in the financials table or ratio section above, investors can evaluate the company's dividend payment history and its commitment to maximizing investor returns.

Poly Medicure Ltd. EPS

Earnings Per Share (EPS) provides valuable insights into Poly Medicure Ltd.'s profitability on a per-share basis. By dividing the net income by the number of outstanding shares, EPS helps investors assess the company's earning potential and growth prospects. Investors can find the EPS data for Poly Medicure Ltd. in the financials table or ratio section above and use it to evaluate the company's financial performance in terms of earnings generated for shareholders per share.  

Poly Medicure Balance Sheet Overview

Poly Medicure's Equity and Liabilities Growth

Poly Medicure has shown notable growth in its equity and liabilities over the recent years. From March 2020 to March 2024, the company's share capital slightly increased from Rs Cr. 44.12 to Rs Cr. 47.99. Total reserves saw a substantial rise from Rs Cr. 385.16 in March 2020 to Rs Cr. 1,410.26 by March 2024, indicating strong retention of earnings and possibly a robust reinvestment strategy.

Poly Medicure's Decreasing Debt

An impressive aspect of Poly Medicure's balance sheet is the significant reduction in borrowings, which plummeted from Rs Cr. 110.57 in March 2020 to a mere Rs Cr. 1.09 by March 2024. This suggests a strategic move towards minimizing debt and potentially signifies a stronger financial health and lower risk profile for the company.

Poly Medicure's Asset Expansion

The asset side of the balance sheet reflects healthy growth. The Net Block, representing tangible assets, grew from Rs Cr. 324.16 in March 2020 to Rs Cr. 830.82 by March 2024, underscoring considerable investments in the company's operational capabilities. Current assets also saw a rise from Rs Cr. 325.40 to Rs Cr. 864.59 in the same period, likely supporting the company's operational liquidity.

This data is an analysis for the Standalone Balance Sheet of the company.

Additionally, Poly Medicure's evolving balance sheet dynamics could be an interesting aspect for those involved in stock screening, offering insights into its financial health and operational efficiency in comparison to other players within the healthcare sector or listed on NSE/BSE indices.

Read More
X